News

  • November 15, 2021

    Bugworks Research Inc. CSO Dr. Santanu Datta underscores need for a Bayh-Dole like Act to propel research commercialization

  • November 10, 2021

    Bugworks Research starts first human dose study to treat critical bacterial infections - ETHealthWorld

  • November 9, 2021

    Bugworks Research begins first in human phase 1 study of BWC0977 to treat critical bacterial infections

  • November 8, 2021

    Indian innovation at work: Bugworks embarks on phase I trials in its pursuit for a new antibiotic

  • November 8, 2021

    Bugworks is proud to announce First in Human phase 1 studies of BWC0977 for the treatment of critical bacterial infections - first novel broad spectrum in decades

  • September 21, 2021

    Dr. Santanu Datta explores the future of drug development and the tension between access and excess

  • July 15, 2021

    Bugworks Co-Founder Bala Subramanian features in the FORBES India Marquee edition on ‘Leaders by Example”

  • June 11, 2021

    Bugworks one of four global companies exemplified in this latest AMR report from Access to Medicines Foundation

  • June 6, 2021

    G7 health ministers make AMR an important facet of pandemic preparedness and vow to incentivise this space

  • May 25, 2021

    Bugworks featured amongst the top 5 innovative Biotech companies to look out for in India by Pharmareg News.

  • April 27, 2021

    Bugworks secures support from US Government's Defense Threat Reduction Agency (DTRA) to validate its clinical asset against the toughest bacterial biothreats

  • April 26, 2021

    Dr. Oppel Greeff, Bugworks’ investor and member of SAB, wins the prestigious Havengaprize by the South Africa Academy of Art and Science

  • April 22, 2021

    Bugworks’ CEO interviewed by the Financial Express as part of a story done on World innovation day!

  • April 15, 2021

    Anand Anandkumar, Bugworks’ CEO has been re-nominated into the Board of AMR Industry Alliance and will serve as key member of the Biotech Working Group within this global alliance.

  • April 12, 2021

    Anand Anandkumar has been selected by CEO Insights Magazine for 'Top 10 Best Leaders in Biotechnology in India 2021'

  • March 15, 2021

    Bugworks on BBC’s people fixing the world podcast.

  • March 02, 2021

    Bugworks Research, one of the three companies to be showcased in GlobalBioIndia event 2021.

  • February 01, 2021

    Japanese venture company UTEC - The University of Tokyo Edge Capital Partners is enabling world class innovation from India in lifesciences - Bugworks Research Inc. as an exemplar!

  • January 25, 2021

    ALCOR Fund has chosen Bugworks as one of top 10 most innovative biotech startups in India

  • January 18, 2021

    Bugworks showcased as pioneering start-up in Indian biotech, attracting global funding.

  • January 11, 2021

    Dr.Anand Anandkumar Co-Founder and CEO of Bugworks Research Inc. has been inducted into Basel area innovation India Board (BIIB).